Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

Predictive factors of repeat therapy in patients receiving iodine-131 for Graves’ disease

Ruiguo Zhang, Lan Qin, Zhong Ren and Junqi Wang
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 36;
Ruiguo Zhang
1Department of Nuclear Medicine, Tianjin First Central Hospital, Tianjin, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lan Qin
1Department of Nuclear Medicine, Tianjin First Central Hospital, Tianjin, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhong Ren
1Department of Nuclear Medicine, Tianjin First Central Hospital, Tianjin, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junqi Wang
1Department of Nuclear Medicine, Tianjin First Central Hospital, Tianjin, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 36

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Ruiguo Zhang1,
  2. Lan Qin1,
  3. Zhong Ren1 and
  4. Junqi Wang1
  1. 1Department of Nuclear Medicine, Tianjin First Central Hospital, Tianjin, China

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014200
Dec 2014600
Feb 2015100
Mar 2015200
Apr 2015200
Jun 2015400
Jul 20154400
Aug 2015900
Sep 2015600
Oct 2015100
Jan 2016100
Feb 2016300
Mar 2016900
Apr 2016600
May 2016500
Jun 2016100
Jul 2016200
Aug 2016200
Sep 20161100
Oct 2016300
Nov 2016300
Dec 2016500
Jan 2017700
Feb 2017300
Mar 2017300
Apr 2017600
May 2017700
Jun 2017600
Jul 2017500
Aug 2017700
Sep 20172200
Oct 20171400
Nov 2017600
Dec 2017100
Jan 2018300
Feb 2018600
Mar 2018800
Apr 2018100
May 2018100
Jul 2018400
Aug 2018200
Sep 2018100
Oct 2018300
Nov 2018300
Dec 2018200
Feb 2019200
Mar 2019100
Apr 20191700
May 2019400
Aug 2019400
Sep 2019200
Oct 2019100
Nov 2019100
Jan 2020100
Feb 2020500
Mar 20201600
Apr 2020800
Jul 2020400
Aug 20201400
Sep 20202000
Oct 20201600
Nov 20201600
Dec 20201100
Jan 2021600
Feb 20211900
Mar 20211500
Apr 20211900
May 2021700
Jun 20211200
Jul 20211900
Aug 20212900
Sep 20211200
Oct 20214000
Nov 20215500
Dec 20213700
Jan 20226500
Feb 20221900
Mar 20221100
Apr 2022900
May 20222200
Jun 2022300
Jul 2022400
Aug 2022500
Sep 2022400
Oct 2022200
Nov 2022100
Dec 2022100
Jan 2023200
Feb 2023200
Mar 2023200
Apr 2023400
May 2023100
Jun 2023200
Jul 2023400
Aug 2023200
Sep 2023200
Oct 2023500
Nov 2023400
Dec 2023700
Jan 2024600
Feb 2024600
Mar 2024600
Apr 2024300
May 2024700
Jun 2024500
Jul 20245200
Aug 20245300
Sep 20241100
Oct 2024400
Nov 2024800
Dec 2024700
Jan 2025900
Feb 2025500
Mar 2025600
Apr 20251200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Predictive factors of repeat therapy in patients receiving iodine-131 for Graves’ disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Predictive factors of repeat therapy in patients receiving iodine-131 for Graves’ disease
Ruiguo Zhang, Lan Qin, Zhong Ren, Junqi Wang
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 36;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Predictive factors of repeat therapy in patients receiving iodine-131 for Graves’ disease
Ruiguo Zhang, Lan Qin, Zhong Ren, Junqi Wang
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 36;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • COMMON PEDIATRIC NUCLEAR MEDICINE IMAGING STUDIES: A COMPREHENSIVE REVIEW
  • COVID-19 and Nuclear Medicine: what we know so far…
  • Utility of Depth Correction Calculator for Split Renal Function Studies utilizing prior CT or MRI
Show more General Clinical Specialties

Endo I: Benign Thyroid Diseases

  • Regulatory role of selenium on the biokinetics of I-131 following lithium treatment
  • The long term effects of radio-iodine therapy versus antithyroid medications on Graves' disease
Show more Endo I: Benign Thyroid Diseases

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire